Literature DB >> 91323

Molecular forms of immunoreactive pancreatic cationic trypsin in pancreatitis patient sera.

J W Brodrick, M C Geokas, C Largman, M Fassett, J H Johnson.   

Abstract

The molecular forms of immunoreactive pancreatic cationic trypsin in sera of patients with acute pancreatic inflammation have been characterized using a radioimmunoassay technique that is capable of detecting trypsinogen as well as trypsin bound to alpha 1-antitrypsin. Trypsin bound to alpha 2-macroglobulin is not immunoreactive under normal assay conditions. However, alpha 2-macroglobulin-bound trypsin can be detected after gel filtration of serum on Bio-Gel A-0.5 m and acid treatment of column fractions. The average serum level of immunoreactive cationic trypsin from 20 patients with acute pancreatic inflammation was 1,590 ng/ml. An average normal value of 26 ng/ml has been obtained previously. Serum samples from 14 patients with pancreatic inflammation were chromatographed under conditions that resolve trypsinogen, alpha 1-antitrypsin-bound trypsin, and alpha 2-macroglobulin-bound trypsin. In each case, the major portion of the immunoreactive material eluted at a position corresponding to free trypsinogen, while a minor fraction of the immunoreactive material appeared to be trypsin bound to alpha 1-antitrypsin. The zymogen nature of the major peak was confirmed in one case by activation with human enteropeptidase. In 11 of 14 patients, acid treatment of the alpha 2-macroglobulin peak yielded immunoreactive trypsin.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 91323     DOI: 10.1152/ajpendo.1979.237.5.E474

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  16 in total

1.  Relationship between circulating levels of pancreatic proteolytic enzymes and pancreatic hormones.

Authors:  Sakina H Bharmal; Sayali A Pendharkar; Ruma G Singh; Mark O Goodarzi; Stephen J Pandol; Maxim S Petrov
Journal:  Pancreatology       Date:  2017-09-20       Impact factor: 3.996

2.  Immunoreactive trypsin in acute pancreatitis: elevated levels do not correlate with hyperamylasaemia.

Authors:  G J Poston; A S Adamson; A F Heeley; M E Heeley; E Hughes; I S Benjamin
Journal:  Ann R Coll Surg Engl       Date:  1987-09       Impact factor: 1.891

Review 3.  Acute necrotising pancreatitis--a role for enterokinase.

Authors:  D Grant
Journal:  Int J Pancreatol       Date:  1986-10

4.  Fatal pancreatitis, a consequence of excessive leukocyte stimulation?

Authors:  H Rinderknecht
Journal:  Int J Pancreatol       Date:  1988-03

5.  Molecular forms of serum pancreatic stone protein in acute pancreatitis.

Authors:  Y Nakae; S Naruse; M Kitagawa; H Ishiguro; M Kato; S Hayakawa; T Kondo; T Hayakawa
Journal:  Int J Pancreatol       Date:  1999-02

6.  Impaired mononuclear phagocyte function in patients with severe acute pancreatitis: evidence from studies of plasma clearance of trypsin and monocyte phagocytosis.

Authors:  M Larvin; D J Alexander; S F Switala; M J McMahon
Journal:  Dig Dis Sci       Date:  1993-01       Impact factor: 3.199

7.  Pulmonary involvement in chronic pancreatitis.

Authors:  G Masoero; S Spinaci; W Arossa; A Andriulli; E Gaia; G De Pretis; G Dobrilla; M De la Pierre
Journal:  Dig Dis Sci       Date:  1984-10       Impact factor: 3.199

8.  Serum immuno reactive trypsin and pancreatic isoamylase in older patients with cystic fibrosis.

Authors:  M J Tobin; M J Duffy; G Duffy; M X FitzGerald
Journal:  Ir J Med Sci       Date:  1981-11       Impact factor: 1.568

9.  Biochemical studies in peritoneal fluid from patients with acute pancreatitis. Relationship to etiology.

Authors:  M A Dubick; A D Mayer; A P Majumdar; G Mar; M J McMahon; M C Geokas
Journal:  Dig Dis Sci       Date:  1987-03       Impact factor: 3.199

10.  Diagnostic accuracy of serum cationic trypsinogen estimation for pancreatic diseases.

Authors:  G Masoero; A Andriulli; A Bianco; V Benitti; M Marchetto; M De La Pierre
Journal:  Dig Dis Sci       Date:  1982-12       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.